ClinicalTrials.gg
BiologicalDrug

Pegloticase clinical trials

Also written Krystexxa and Puricase.

studies test it
17
open now
1
in phase 3
4
first study started
2004

How each study uses Pegloticase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pegloticase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Sept 2010 · KRYSTEXXA · BLA 125293 (FDA, Drugs@FDA)
European Union
8 Jan 2013 · Krystexxa · EMEA/H/C/002208 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pegloticase
13
PEG-uricase
2

Brand

Krystexxa
6
Puricase
3

Studies by the year they started

17 studies that test it; most in 2004 (2)

Studies that test Pegloticase, by start year
YearStudies
20042
20062
20081
20121
20151
20181
20192
20202
20212
20221
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
Phase 3
4
Phase 4
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 3

Amgen (8) · Savient Pharmaceuticals (5) · University of Colorado, Denver (1) · M.D. Anderson Cancer Center (1) · Ampel BioSolutions, LLC (1) · John Sundy (1)

Often tested with

Tested in the same studies.

Methotrexate (7)

Studies

Open first, then newest update. How each study uses Pegloticase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Given beside what is tested · 1 — Pegloticase is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Pegloticase

Codes

What other systems call Pegloticase · ClinicalTrials.gg INT002958

  • MeSH (NLM) C031545PegloticaseConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) R581OT55EAPEGLOTICASEConfirmed FDA, NLM, Wikidata
  • RxNorm 1011650Confirmed FDA, Wikidata
  • Wikidata Q7160794pegloticaseConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C97466PegloticaseOne source FDA
  • DrugBank DB09208One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.